Pure Global AI
NCT06010524Recruiting

A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

A Retrospective Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX: Real Life Study
Cerrahpasa Medical Faculty FoundationClinicalTrials.gov
Verified
Study focus
Disease/Condition
Hepatitis C
Study type
Observational
Sponsor & location
Primary sponsor
Cerrahpasa Medical Faculty Foundation
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2023
End date
Dec 31, 2023
Enrollment
450 participants
Primary outcome

Sustained Virology Response 12

Summary

This is a retrospective, non-interventional study. Investigators from infectious diseases and
 gastroenterology departments will participate this study.
 
 Patients data will be collected from hospital medical records.

ICD-10 classifications
Acute hepatitis CChronic viral hepatitis CViral hepatitisChronic viral hepatitisUnspecified viral hepatitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06010524
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06010524 through Pure Global AI's free database. This phase not specified trial is sponsored by Cerrahpasa Medical Faculty Foundation and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 450 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.